Form 8-K · Current Report · Filed 2026-07-28
IQVIA Reports Strong Q2 2026 Results and Raises Full-Year Guidance
IQVIA Holdings Inc. reported strong financial results for the second quarter of 2026, with revenue of $4,368 million, up 8.7% year-over-year. GAAP Net Income was $256 million, and Adjusted EBITDA was $994 million, up 9.2% year-over-year. The company also raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted Earnings per Share, reflecting stronger organic revenue growth and changes in M&A and foreign exchange impacts.
- Filer
- Iqvia Holdings Inc. IQV · NYSE
- Filed
- Accession
- 0001628280-26-049923
- CIK
- 0001478242
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$213.22
Next session
+16.1%
Since filing
+10.2%
Latest close
$235.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from IQV reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, IQV insiders reported 14 Form 4 transactions — net selling of $39.5M.
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Never miss another IQV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.